Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K090208
    Manufacturer
    Date Cleared
    2009-05-22

    (114 days)

    Product Code
    Regulation Number
    888.3350
    Reference & Predicate Devices
    N/A
    Why did this record match?
    Device Name :

    BIOPRO FEMORAL HEADS

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The BioPro Femoral Heads are indicated for use for significantly impaired joints resulting from rheumatoid, osteo, and post-traumatic arthritis; revision of failed femoral head replacement, cup arthroplasty, or other hip procedures; proximal femoral fractures, avascular necrosis of the femoral head; non-union of proximal femoral neck fractures; other indications such as congenital dysplasia, arthrodesis conversion, coxa magna, coxa plana, coxa vara, coxa valga, developmental conditions, metabolic and tumorous conditions, osteomalacia, osteoporosis, pseudarthrosis conversion, and structural abnormalities. The BioPro hip system (PSL) is for cemented and non-cemented use.

    Device Description

    Not Found

    AI/ML Overview

    I am sorry, but the provided text does not contain information about the acceptance criteria or a study proving that a device meets those criteria. The document is an FDA 510(k) clearance letter for the "Biopro Femoral Heads," indicating that the device is substantially equivalent to legally marketed predicate devices.

    The text specifies:

    • Trade/Device Name: Biopro Femoral Heads
    • Regulation Number: 21 CFR 888.3358
    • Regulation Name: Hip joint metal/polymer/metal semi-constrained porous-coated uncemented prosthesis
    • Regulatory Class: II
    • Product Code: LPH, JDI
    • 510(k) Number: K090208
    • Indications For Use: For significantly impaired joints resulting from rheumatoid, osteo, and post-traumatic arthritis; revision of failed femoral head replacement, cup arthroplasty, or other hip procedures; proximal femoral fractures, avascular necrosis of the femoral head; non-union of proximal femoral neck fractures; other indications such as congenital dysplasia, arthrodesis conversion, coxa magna, coxa plana, coxa vara, coxa valga, developmental conditions, metabolic and tumorous conditions, osteomalacia, osteoporosis, pseudarthrosis conversion, and structural abnormalities. The BioPro hip system (PSL) is for cemented and non-cemented use.

    However, it does not include any details on:

    1. A table of acceptance criteria and reported device performance.
    2. Sample sizes or data provenance for a test set.
    3. Number or qualifications of experts for ground truth establishment.
    4. Adjudication method.
    5. Multi-reader multi-case (MRMC) comparative effectiveness study.
    6. Standalone (algorithm only) performance.
    7. Type of ground truth used.
    8. Sample size for the training set.
    9. How ground truth for the training set was established.

    This document is a regulatory approval letter, not a study report or a summary of performance data.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1